Unfortunately, we are unable to locate the alert you have requested.
Research report: Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats
Managing Behavioral and Psychological Symptoms of Dementia
Auris Medical Holding Ag Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jan. 29, 2018)
Newron Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New York
Auris Medical Holding Ag Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Jan. 29, 2018)
Deals Shaping The Medical Industry, February 2018
Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine
Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors
Auris Medical Announces Extraordinary General Meeting of Shareholders

Pages